Objective To describe the clinical characteristics, treatment, and outcomes of a multinational cohort of patients with macrophage activation syndrome (MAS) and thrombotic microangiopathy (TMA)
Macrophage activation syndrome (MAS) belongs to secondary hemophagocytic lymphohistiocytosis (HLH) s...
Thrombotic microangiopathy (TMA) is a rare but life-threatening complication of systemic lupus eryth...
Macrophage activation syndrome (MAS) is a potentially life-threatening complication of rheumatic dis...
Objective To describe the clinical characteristics, treatment, and outcomes of a multinational cohor...
Objective. To describe the clinical, laboratory and histopathologic features, current treatment and ...
Thrombotic microangiopathies (TMAs) are rare, but life-threatening disorders characterized by microa...
MAS, which is currently grouped under secondary or acquired haemophagocytic lymphohistiocytosis (sHL...
Macrophage activation syndrome (MAS) is increasingly recognized among febrile hospitalized patients....
Objective To describe the clinical, laboratory, and histopathologic features, current treatment, and...
Thrombotic microangiopathies (TMAs) are rare, but life-threatening disorders characterized by microa...
Abstract: To characterize clinical and laboratory signs of patients with Still's disease experiencin...
Thrombotic microangiopathies (TMAs) have in common a terminal phenotype of microangiopathic hemolyti...
Background : Thrombotic Microangiopathy (TMA) is defined as a lesion comprising vessel wall thickeni...
Macrophage activation syndrome (MAS) is a serious complication of childhood systemic inflammatory di...
Butsabong Lerkvaleekul, Soamarat Vilaiyuk Division of Rheumatology, Department of Pediatrics, Facult...
Macrophage activation syndrome (MAS) belongs to secondary hemophagocytic lymphohistiocytosis (HLH) s...
Thrombotic microangiopathy (TMA) is a rare but life-threatening complication of systemic lupus eryth...
Macrophage activation syndrome (MAS) is a potentially life-threatening complication of rheumatic dis...
Objective To describe the clinical characteristics, treatment, and outcomes of a multinational cohor...
Objective. To describe the clinical, laboratory and histopathologic features, current treatment and ...
Thrombotic microangiopathies (TMAs) are rare, but life-threatening disorders characterized by microa...
MAS, which is currently grouped under secondary or acquired haemophagocytic lymphohistiocytosis (sHL...
Macrophage activation syndrome (MAS) is increasingly recognized among febrile hospitalized patients....
Objective To describe the clinical, laboratory, and histopathologic features, current treatment, and...
Thrombotic microangiopathies (TMAs) are rare, but life-threatening disorders characterized by microa...
Abstract: To characterize clinical and laboratory signs of patients with Still's disease experiencin...
Thrombotic microangiopathies (TMAs) have in common a terminal phenotype of microangiopathic hemolyti...
Background : Thrombotic Microangiopathy (TMA) is defined as a lesion comprising vessel wall thickeni...
Macrophage activation syndrome (MAS) is a serious complication of childhood systemic inflammatory di...
Butsabong Lerkvaleekul, Soamarat Vilaiyuk Division of Rheumatology, Department of Pediatrics, Facult...
Macrophage activation syndrome (MAS) belongs to secondary hemophagocytic lymphohistiocytosis (HLH) s...
Thrombotic microangiopathy (TMA) is a rare but life-threatening complication of systemic lupus eryth...
Macrophage activation syndrome (MAS) is a potentially life-threatening complication of rheumatic dis...